Terms ending in 2034
Every in-force patent on Cellectis's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,738,289 | Tevi Chimeric Endonuclease and Their Preferential Cleavage Sites In force · High confidence | Cellectis S.A. | In force | High confidence | |
| US 10,584,352 | Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System In force · High confidence | Cellectis | In force | High confidence | |
| US 10,870,864 | Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System In force · High confidence | Cellectis | In force | High confidence | |
| US 11,365,430 | Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System In force · High confidence | Cellectis | In force | High confidence | |
| US 9,855,297 | Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System In force · High confidence | Cellectis | In force | High confidence | |
| US 9,890,393 | Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System In force · High confidence | Cellectis | In force | High confidence | |
| US 10,000,746 | A Laglidadg Homing Endonuclease Cleaving the T Cell Receptor Alpha Gene and Uses Thereof In force · High confidence | 2SEVENTY Bio, Inc. | In force | High confidence | |
| US 10,006,052 | A Laglidadg Homing Endonuclease Cleaving the C-C Chemokine Receptor TYPE-5 (CCR5) Gene and Uses Thereof In force · High confidence | 2SEVENTY Bio, Inc. | In force | High confidence | |
| US 11,576,317 | Mutant Nicotiana Benthamiana Plant or Cell with Reduced Xylt and Fuct In force · High confidence | Cellectis S.A. | In force | High confidence | |
| US 10,113,162 | Modifying Soybean Oil Composition Through Targeted Knockout of the FAD2-1A/1B Genes In force · High confidence | Cellectis | In force | High confidence | |
| 6 more term ends in 2034 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
14 of these are in force and held by Cellectis.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.